Agios Pharmaceuticals Inc (AGIO)

54.13
1.21 2.29
NASDAQ : Health Care
Prev Close 52.92
Open 53.03
Day Low/High 52.69 / 54.47
52 Wk Low/High 33.50 / 119.92
Volume 409.42K
Avg Volume 579.50K
Exchange NASDAQ
Shares Outstanding 42.23M
Market Cap 2.24B
EPS -3.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotechs Among 5 Stocks Setting Up for Major Breakouts

Biotechs Among 5 Stocks Setting Up for Major Breakouts

Here's how to rake in the profits off some potential big breakouts.

FDA Accepts New Drug Application And Grants Priority Review For Enasidenib In Relapsed Or Refractory AML With An IDH2 Mutation

FDA Accepts New Drug Application And Grants Priority Review For Enasidenib In Relapsed Or Refractory AML With An IDH2 Mutation

Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals (NASDAQ:AGIO) today announced that the U.

Analysts' Actions -- Chipotle, Disney, Brinker, JPMorgan and More

Analysts' Actions -- Chipotle, Disney, Brinker, JPMorgan and More

Here are Tuesday's top research calls, including upgrades for Disney, Continental Resources and Agios Pharmaceuticals, and downgrades for Chipotle, Brinker International and JPMorgan Chase.

Agios Shelves Rare Anemia Disorder Drug Due to Liver Toxicity, Switches to Backup

Agios Shelves Rare Anemia Disorder Drug Due to Liver Toxicity, Switches to Backup

Agios owns the full rights to both drugs in the PKD development program, which makes them particularly important to the company.

Agios Provides Update On PKR Program

Agios Provides Update On PKR Program

Flagship Ventures Evolves Name To Flagship Pioneering

Flagship Ventures Evolves Name To Flagship Pioneering

Announces Innovative $285 Million Follow-on Capital Pool for Special Opportunities

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Agios Pharmaceuticals, Inc. And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Agios Pharmaceuticals, Inc. And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Agios Pharmaceuticals, Inc.

Why Celgene Is a Core Biotech Holding

Why Celgene Is a Core Biotech Holding

Celgene's days of stellar growth will continue to stretch far into the future.

Celgene And Agios Announce Collaborations With Abbott For Diagnostic Identification Of IDH Mutations In AML

Celgene And Agios Announce Collaborations With Abbott For Diagnostic Identification Of IDH Mutations In AML

Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced each company has entered into collaboration agreements with Abbott (NYSE: ABT), a leader in diagnostic technologies, to develop...